Obesity Rates Plateau in Developed Nations While Accelerating in Poorer Countries
A new analysis published in Nature reveals a divergence in global obesity trends, with rates stabilizing in high-income nations but rising rapidly in low- and middle-income countries.

Diverging Global Trends
An analysis of global obesity trends since the 1980s indicates that the rise of obesity has slowed, stabilized, and in some cases reversed in many nations. According to a study published in Nature by Bin Zhou et al., the rise in obesity has plateaued in developed nations while continuing to accelerate in developing nations.
While obesity prevalence has increased in almost every country over the past few decades, the pace of this increase varies significantly by region. In many high-income countries, the trend has shifted toward a plateau. In contrast, obesity rates have continued to climb in low- and middle-income countries over the last 45 years.
Impact on Youth in High-Income Nations
The study highlights specific trends among younger populations in wealthier regions. In many high-income countries, the rise in obesity among school-aged children and adolescents decelerated throughout the 1990s.
This stabilization in developed nations challenges the previous assumption that obesity is a linear "global epidemic" with inevitable growth across all territories. Researchers noted that because the rise is not inevitable, the data provides a basis for understanding how these trends can be managed or reversed.
Acceleration in Lower-Income Regions
While wealthier nations see a leveling off, the burden of obesity is shifting toward poorer nations. The Nature report confirms that obesity is rising at a faster pace in lower-income countries than in high-income ones.
This acceleration suggests a global shift in the distribution of the health crisis. While the prevalence has been increasing globally, the disparity in the speed of growth between high-income and low-income countries has become more pronounced.
Sources (8)Open
- 1.Nature — Obesity rise plateaus in developed nations and accelerates in developing nations
- 2.Ac — Obesity rates levelling off and even declining in many nations, says global progress report | Imperial News | Imperial College London
- 3.Nature — Obesity has risen in all countries — but at a faster pace in poorer ones
- 4.Sciencemediacentre — expert reaction to an analysis of global obesity trends
- 5.Theguardian — Obesity rates in some countries levelling off or potentially falling ...
- 6.Nih — Obesity rise plateaus in developed nations and accelerates ... - PubMed
- 7.Asiaresearchnews — Obesity rising faster in lower-income countries | Asia Research News
- 8.Msn — Why obesity is rising faster in developing nations, reveals a study
Topics
How NewsNews AI made this storyOpen
NewsNews AI researched this story across 8 sources, drafted it, and ran the result through an independent editorial pass. It cleared editorial review on first pass.
- 8 sources cited · linked in full at the bottom of the article
- Image license verified · cc-by-sa
- Independent editorial pass · approved
From the editor
Verified all major claims against available snippets. The core findings — plateau in high-income nations, acceleration in low- and middle-income countries, deceleration among youth in the 1990s, and the challenge to the "global epidemic" narrative — are all supported by the cited source snippets. Citations are correctly attributed throughout the body and key facts. Source 1 has no snippet but is corroborated by sources 4, 6, and 7 which reference the same Nature study by Bin Zhou et al. No fabricated quotes, no unsupported overreach, and no contradictions detected.
Feedback
We want to hear from you, especially when something is wrong. No signup, no email required.
Keep reading

Global Migration Movements Surged to 35 Million Annually by 2023
New research utilizing deep learning reveals that annual global migration rose from 13 million in 2000 to approximately 35 million people by 2023.

GLP-1 Weight Loss Drugs Linked to 30% Lower Breast Cancer Risk
A large study of women undergoing breast imaging suggests that GLP-1 medications may reduce the likelihood of developing breast cancer.

Experimental Pill Nearly Doubles Survival Time for Advanced Pancreatic Cancer
Clinical trial data shows daraxonrasib extends median survival to 13.2 months compared to 6.7 months for chemotherapy in patients with metastatic pancreatic cancer.